ScholarLens Back to search
2008•Journal of clinical researchRequires access

Study on BNP for Early Risk Stratification of Patients with Acute Coronary Syndrome of Non-ST-Segment Elevation

Suning Chen

Open publisher page 0 citations

Abstract

[Objective] To investigate the role of brain natriuretic peptide(BNP)in early risk stratification of patients with acute coronary syndrome of non-ST-segment elevation,and to find the patients with high risks.[Methods] The level of BNP in 62 patients with acute coronary syndromes of non-ST elevation from Jan.2007 to Jul.2007 in the Shengjing Hospital Affiliated to China Medical University were measured,and the lesion extent of coronary artery was assessed by angiography.Sixty-day follow-up was performed for all patients.[Results]The higher BNP level in patients was related to multivessel coronary artery disease and poor prognosis(P0.05).[Conclusion]The measurement of BNP is available for the early risk stratification of patients with acute coronary syndrome of non-ST elevation.Early BNP measurement could provide more prognostic information.

About this research paper

What this paper is about

[Objective] To investigate the role of brain natriuretic peptide(BNP)in early risk stratification of patients with acute coronary syndrome of non-ST-segment elevation,and to find the patients with high risks.[Methods] The level of BNP in 62 patients with acute coronary syndromes of non-ST elevation from Jan.2007 to Jul.2007 in the Shengjing Hospital Affiliated to China Medical University were measured,and the lesion extent of coronary artery was assessed by angiography.Sixty-day follow-up was performed for all patients.[Results]The higher BNP level in patients was related to multivessel coronary artery disease and poor prognosis(P0.05).[Conclusion]The measurement of BNP is available for the early risk stratification of patients with acute coronary syndrome of non-ST elevation.Early BNP measurement could provide more prognostic information.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To investigate the role of brain natriuretic peptide(BNP)in early risk stratification of patients with acute coronary syndrome of non-ST-segment elevation,and to find the patients with high risks.[Methods] The level of BNP in 62 patients with acute coronary syndromes of non-ST elevation from Jan.2007 to Jul.2007 in the Shengjing Hospital Affiliated to China Medical University were measured,and the lesion extent of coronary artery was assessed by angiography.Sixty-day follow-up was performed for all patients.[Results]The higher BNP level in patients was related to multivessel coronary artery disease and poor prognosis(P0.05).[Conclusion]The measurement of BNP is available for the early risk stratification of patients with acute coronary syndrome of non-ST elevation.Early BNP measurement could provide more prognostic information.

Key concepts: Medicine, Acute coronary syndrome, Internal medicine, Risk stratification, Cardiology, ST elevation, ST segment, Artery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Study on BNP for Early Risk Stratification of Patients with Acute Coronary Syndrome of Non-ST-Segment Elevation — Research Paper | ScholarLens